COVID-19急性呼吸衰竭患者ECMO期间颅内出血:全国登记研究
基于德国COVID-19尸检登记(DeRegCOVID)的全国登记研究,2021年11月共纳入1129例确诊COVID-19尸检病例,其中ECMO尸检63例、非ECMO尸检1066例,来自29个德国中心。结果显示ECMO病例出血事件更常见(56% vs 9%),颅内出血在ECMO组为21%、非ECMO组为3%,且颅内出血被判定为死亡直接或基础原因在ECMO组为78%、非ECMO组为37%。ECMO组最常见三个直接死因为多器官衰竭、ARDS和颅内出血;非ECMO组为ARDS、多器官衰竭和肺部细菌±真菌重叠感染。作者认为该研究提示尸检及跨学科多中心(全国)协作对处理COVID-19致命并发症的潜在价值。
要点
- ECMO尸检病例颅内出血发生率21%,非ECMO尸检病例3%。
- ECMO病例出血事件发生率56%,非ECMO病例9%。
- 颅内出血为死亡直接或基础原因:ECMO组78%,非ECMO组37%。
- ECMO组最常见直接死因为多器官衰竭、ARDS和颅内出血。
- 非ECMO组最常见直接死因为ARDS、多器官衰竭和肺部细菌±真菌重叠感染。
适用人群与场景
- 德国COVID-19尸检登记(DeRegCOVID)中确诊COVID-19的尸检病例,包括ECMO尸检病例63例和非ECMO尸检病例1066例。
研究设计与关键结果
- 全国登记研究,2021年11月登记纳入N=1129例确诊COVID-19尸检病例,其中ECMO尸检63例、非ECMO尸检1066例,来自29个德国中心。
- ECMO用于更年轻的男性患者。
- 出血事件在ECMO病例为56%、非ECMO病例为9%。
- 颅内出血在ECMO病例为21%、非ECMO病例为3%。
- 颅内出血被判定为死亡直接或基础原因在ECMO病例为78%、非ECMO病例为37%。
- ECMO病例三个最常见直接死因依次为多器官衰竭、ARDS和颅内出血;非ECMO病例依次为ARDS、多器官衰竭和肺部细菌±真菌重叠感染。
证据类型、等级与局限
- 证据类型:基于德国COVID-19尸检登记(DeRegCOVID)的全国登记研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该研究提示尸检及跨学科多中心(全国)协作对处理COVID-19致命并发症具有潜在价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In severe cases, SARS-CoV-2 infection leads to acute respiratory distress syndrome (ARDS), often treated by extracorporeal membrane oxygenation (ECMO). During ECMO therapy, anticoagulation is crucial to prevent device-associated thrombosis and device failure, however, it is associated with bleeding complications. In COVID-19, additional pathologies, such as endotheliitis, may further increase the risk of bleeding complications. To assess the frequency of bleeding events, we analyzed data from the German COVID-19 autopsy registry (DeRegCOVID).
METHODS: The electronic registry uses a web-based electronic case report form. In November 2021, the registry included N = 1129 confirmed COVID-19 autopsy cases, with data on 63 ECMO autopsy cases and 1066 non-ECMO autopsy cases, contributed from 29 German sites.
FINDINGS: The registry data showed that ECMO was used in younger male patients and bleeding events occurred much more frequently in ECMO cases compared to non-ECMO cases (56% and 9%, respectively). Similarly, intracranial bleeding (ICB) was documented in 21% of ECMO cases and 3% of non-ECMO cases and was classified as the immediate or underlying cause of death in 78% of ECMO cases and 37% of non-ECMO cases. In ECMO cases, the three most common immediate causes of death were multi-organ failure, ARDS and ICB, and in non-ECMO cases ARDS, multi-organ failure and pulmonary bacterial ± fungal superinfection, ordered by descending frequency.
INTERPRETATION: Our study suggests the potential value of autopsies and a joint interdisciplinary multicenter (national) approach in addressing fatal complications in COVID-19.
参考来源
- von Stillfried S, Bülow RD, Röhrig R, et al. Intracranial hemorrhage in COVID-19 patients during extracorporeal membrane oxygenation for acute respiratory failure: a nationwide register study report. Crit Care. 2022. PMID: 35346314. doi:10.1186/s13054-022-03945-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。